Castle Rock Wealth Management, LLC Crispr Therapeutics Ag Transaction History

Castle Rock Wealth Management, LLC

  • $345 Million
  • Q1 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 11, 2019
SELL
$22.73 - $42.34 $164,928 - $307,219
-7,256 Closed
0 $0
Q3 2018

Nov 13, 2018
SELL
$44.35 - $65.71 $135,977 - $201,466
-3,066 Reduced 29.7%
7,256 $254,000
Q2 2018

Aug 13, 2018
BUY
$42.62 - $73.59 $81,063 - $139,968
1,902 Added 22.59%
10,322 $607,000
Q1 2018

May 14, 2018
BUY
$23.52 - $58.17 $198,038 - $489,791
8,420 New
8,420 $385,000

Others Institutions Holding CRSP

# of Institutions
479
Shares Held
64.2M
Call Options Held
2.15M
Put Options Held
1.92M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $2.83B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Castle Rock Wealth Management, LLC Portfolio

Follow Castle Rock Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castle Rock Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castle Rock Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email